Rice University researchers are starting to understand how protein fragments influence the fiber aggregation suspected as a cause of Huntington’s disease.
In their computer simulations, Rice bioscientist Peter Wolynes and graduate student Mingchen Chen show that the N-terminal sequence in huntingtin protein fragments encourages their aggregation into prefibrillar structures, while a C-terminal sequence made up of polyproline inhibits aggregation.
The models suggest their combined actions are part of the aggregation mechanism they described in a previous study about how repeats of polyglutamine genetically trigger Huntington’s.
Wolynes said the discovery offers hope for drugs that could interfere with N-terminal binding and thereby stop aggregation early in the process. “Finding a target involves understanding molecular mechanisms and how things work at the atomic level, and we’re adding to that part of the story,” he said.
The research is detailed in the Proceedings of the National Academy of Sciences.
Huntington’s is a hereditary disease caused by a mutation in the gene that expresses huntingtin proteins, which are common in human neurons and mostly harmless. The mutation involves a repeating chain of glutamines, which increases in length as genes are passed down through generations. Eventually, when the length surpasses a threshold, aggregation is triggered. Fibers typically begin to aggregate in Huntington’s when these polyglutamine chains reach a critical length of 36 repeats. Longer chains can make the disease more severe and its onset earlier.
The Rice lab studies the molecular energy landscapes that allow proteins to fold into their functional shapes. This time, the researchers looked at the protein fragments that remain in a cell after the proteolysis – or breakdown – of large huntingtin proteins. These hairpin-like fragments contain polyglutamines capped on either end by an N-terminus and a C-terminus.
Wolynes and Chen found that the N- and C-termini are like children on either end of a see-saw: They must be in balance to stabilize fragments with long polyglutamine chains. If they are not, the fragments begin to form inclusion bodies, the aggregates found inside the cells of people with Huntington’s.
“If you only had the N-terminus encouraging aggregation and you didn’t have the polyproline at the other end, then everyone would get Huntington’s disease,” Wolynes said. “So the prolines are doing something clinically good, but we don’t know why it has evolved that way.”
Wolynes said the core process by which polyglutamines fold prematurely when their length is beyond the threshold remains the same as for peptides lacking the termini, “but it’s modified quantitatively by the influence of the two ends.” Some people may harbor huntingtin proteins with long polyglutamines that are prevented from causing disease by the presence of longer polyprolines, he said.
Altering the N-terminus may also halt progression of the disease. “What would happen if we change a single amino acid in the N-terminus? We can use our models to look into that,” Wolynes said. “If there are people with 40 polyglutamines but who also have a mutation in the N-terminus head and they don’t get Huntington’s, that would be very interesting.
“But that’s a very tricky thing to prove,” he said. “If somebody doesn’t have Huntington’s disease, they usually don’t come in and say, ‘Check me out!’ Still, this argues for finding drugs that modify N-terminal binding.”
The researchers’ simulations predicted that the critical length of fragments prone to aggregation is between 30 and 40 glutamines, which is “remarkably consistent with the critical length for disease onset,” they wrote.
“Before, we showed there’s a critical length (of 30 glutamines) for this pre-folding transition into hairpin shapes, but that length was shorter than the actual disease onset length (of 36),” Wolynes said. “When you put on these two termini, the length of the protein moves up to the range where the disease onset actually occurs.
“This tends to point to aggregation itself as the cause of the illness, even though some have suggested that aggregation is a protective mechanism.”
He said the results also underline the involvement of the cytoskeleton. Wolynes noted that the huntingtin protein is known to interact with at least four proteins linked to the cytoskeleton, the network of filaments that direct the transport around a cell. He said experiments have established that the cytoskeleton helps bring fragments together as they aggregate.
“I tend to think the weird involvement of the cytoskeleton is a clue, and the fact it’s involved in other neural processes like long-term memory has a certain suspicious air about it,” he said.
Wolynes said the Rice lab may probe proteolysis, in which enzymes cut larger proteins into fragments. “In almost all of the neurodegenerative diseases, including Alzheimer’s and Huntington’s, the aggregates that signify the presence of the disease are the result of proteolytic cleavage,” he said. “Proteolysis seems to have evolved to cleave proteins at a specific point to do something functional, which suggests it’s not merely an accident.”
Wolynes is the D.R. Bullard-Welch Foundation Professor of Science, a professor of chemistry, of biochemistry and cell biology, of physics and astronomy and of materials science and nanoengineering at Rice and a senior investigator of the National Science Foundation (NSF)-funded Center for Theoretical Biological Physics at Rice.
The National Institute of General Medical Sciences supported the research. The researchers used the NSF-supported DAVinCI supercomputer administered by Rice’s Center for Research Computing and procured in partnership with the Ken Kennedy Institute for Information Technology.
Baylor College of MedicineBaylorCollegeOfMedicine
Congratulations to Dr. Xiang Zhang on being the 2018 Sue Eccles Young Investigator Award recipient from the Metastasis Research Society. #research #awards
Start off your morning on a tropical note with our Sugar, Heart, and Life Program's mango shake! https://t.co/TQxtiWD5yO
New memorial for paratroopers dedicated at Miramar @VANatCemeteries https://t.co/E15jycKj5X via @sdut
Are you on LinkedIn? Be sure to follow Rice University! https://t.co/aZqRiSLgYI
MD Anderson Cancer Center@MDAndersonNews
“#Lynchsyndrome is seriously underdiagnosed.” Learn how one of our doctors is helping raise awareness for a genetic syndrome that increases #cancer risk: https://t.co/yTyF65p0Zr #endcancer https://t.co/70Ok973o84
From baldness & infertility to high blood pressure & increased risk of heart attack, the side effects of steroid use may have a more serious health impacts than you thought.
Legacy project to tell the stories of Veterans interred at Riverside @VANatCemeteries https://t.co/Tu7MCotplc via #VAntagePoint
RT @culturemap: Medical Center's magical Match Day means start of Houstonians' dreams https://t.co/thisTyCaGe
RT @UTCVSurgery: Dr. Tom Nguyen Awarded First Place for #ACC’s Transcatheter Heart Valve Handbook! Read more here: https://t.co/P9Vz8iq6wi
RT @UTCVSurgery: Have you registered for The Inaugural Houston AFib Patient Experience Seminar yet? Read more here: https://t.co/Z0a8ftrol…
The Hurricane Harvey Relief Fund has awarded $2.6 million to The University of Texas Health Science Center at Houston (UTHealth) for a technology-supported program for patients with unmet post-Harvey behavioral health needs.
University of Houston@UHouston
@ohnosydneylo It’s perfect! https://t.co/A7jp3WeclR
U.S. Department of Veterans AffairsVeteransAffairs
Today's #VeteranOfTheDay is Army Veteran Les Payne. Les was born July 12, 1941 in Tuscaloosa, Alabama. He received a degree from University of Connecticut in 1964 and went on to serve in the Vietnam War during a tour with the Army. After his time in the military, Les joined Newsday in 1969. Les was part of the Newsday reporting team that created a 33-part series tracking heroin from growth in Turkey to being sold in America. "The Heroin Trail" won a Pulitzer Prize in 1974. Les was a founding member and former president of the National Association of Black Journalists. He retired in 2006, spending nearly four decades at Newsday and setting the standard for excellent journalism. Les died Monday night at his home in Harlem. We honor his service.
Today's #VeteranOfTheDay is @USArmy Veteran Les Payne. Les was a founder and former president of @NABJ, @PulitzerPrizes winner, and long time reporter for @Newsday.
Billing issues. Call center unable to help & there is simply no complaints or escalation number!!!!